Immunization of Human Volunteers With Hepatitis C Virus Envelope Glycoproteins Elicits Antibodies That Cross-Neutralize Heterologous Virus Strains
Open Access
- 1 September 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 204 (5) , 811-813
Abstract
TO THE EDITOR—Ray and colleagues recently demonstrated hepatitis C virus (HCV) glycoprotein-specific neutralizing responses against homologous HCV-1 and the closely related genotype 1a HCV strain H77 [1]. Using well-characterized pseudoparticle (HCVpp) and cell culture replicating virus systems (HCVcc) [2], we set out to further investigate the breadth of the neutralizing responses elicited by vaccination. We tested serum samples from 8 of the volunteers reported in the study by Ray et al [1], selecting representative samples that had low, intermediate, and high anti-E1E2 antibody titers as measured by enzyme immunoassay (Novartis Vaccines and Diagnostics, Emeryville, CA).Keywords
This publication has 6 references indexed in Scilit:
- Characterization of Antibodies Induced by Vaccination with Hepatitis C Virus Envelope GlycoproteinsThe Journal of Infectious Diseases, 2010
- Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?Nature Medicine, 2009
- Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver–chimeric mice from infection with a homologous hepatitis C virus strainHepatology, 2008
- Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodiesHepatology, 2007
- Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challengeNature Medicine, 2007
- Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodiesVaccine, 2007